The Deal

OCTOBER 17, 2023

Direct-to-consumer businesses, darlings of the investor community in 2021, saw their techlike valuations plummet. But some subsectors, such as beauty, fragrance, residential services and medical spas, remained active as risk-off investors shifted deal activity toward categories they view as less discretionary, according to Leonhardt.

M&A 64

M&A IPO Retail Medical 64

Focus Investment Banking

MARCH 28, 2024

Summary Private equity’s investments in ophthalmology are entering a new, more mature lifecycle phase. We also expect many platform recapitalizations once private equity groups and lenders become comfortable with the interest rate environment. For example, all affiliated practices are in the Southeastern US.

Private Equity 52

Private Equity Equities Valuation Acquisitions 52

Peak Frameworks

SEPTEMBER 19, 2023

If you're interested in breaking into finance, check out our , Private Equity Course and , Investment Banking Course , which help thousands of candidates land top jobs every year. Example: Medications for rare diseases, where research costs are high and patient populations are small, can often command high prices.

Private Equity 52

Private Equity Business Profitability Investment Banking 52

Growth Business

JUNE 1, 2023

By Dom Walbanke on Growth Business - Your gateway to entrepreneurial success Angel investing is early-stage equity investment from high-net-worth individuals. It is a form of equity funding that precedes venture capital and private equity. Ideally, the product will also be protected with IP.

Investment 52

Investment Business Investors Funds 52

Cooley M&A

JANUARY 23, 2024

Complex and novel transaction structures for the sector also were a prominent result of the market and regulatory environment, with reverse mergers remaining a fixture and stock-for-stock deals and take-private transactions led by private equity sponsors entering the scene. billion.

M&A 52

M&A Mergers and Acquisitions Acquisitions Pharmaceutical 52

Growth Business

NOVEMBER 23, 2023

Despite investment in the first half of 2023 dropping to £4.6bn from 2022’s £10.8bn as a result of rising interest rates, high inflation, a decrease in valuations and geopolitical tensions globally, UK fintechs are still attracting more VC investment than all other EMEA fintechs combined, with a significant percentage coming from US investors.

Investment 95

Investment Funds Capital Business 95

Mergers and Inquisitions

NOVEMBER 1, 2023

When you hear the words “healthcare private equity,” two thoughts probably come to mind: Wait a minute, isn’t healthcare a risky/growth-oriented sector? In most of the world, healthcare is either government-run or a mixed public/private sector. Are there many private healthcare companies for PE firms to acquire?

Private Equity 59

Private Equity Healthcare Equities Middle Market 59

How2Exit

AUGUST 2, 2023

This has led to a surge in AI adoption across various industries, including finance, law, and private equity. They discuss the potential of AI and how it can enhance due diligence, valuation, and integration processes. ChatGPT allows users to input a question or prompt and receive an instantaneous response.

Mergers and Acquisitions 130

Mergers and Acquisitions Mergers Acquisitions M&A 130

Solganick & Co.

JANUARY 9, 2024

Despite a somewhat cautious start to the year due to challenging economic conditions and valuation discrepancies between buyers and sellers, the sector saw a robust recovery in the latter half. Billion): Private equity firm Thoma Bravo acquired NextGen Healthcare for an enterprise value of $1.8

Healthcare 52

Healthcare M&A IT Mergers and Acquisitions 52

Cooley M&A

JANUARY 25, 2023

However, deal activity fizzled in the second half of 2022, as high inflation, aggressive anti-inflation monetary policies, geopolitical instability, assertive antitrust regulators and tightening financing markets depressed target valuations, reduced strategic acquirer confidence and sidelined private equity sponsor buyers.

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Cooley M&A

JANUARY 20, 2022

Midsize pharmaceutical buyers pursuing opportunistic acquisition strategies, with robust capital markets and high valuations having limited the pool of attractive assets available in recent years. billion strategic combination of One Medical and Iora Health – used all stock. [9] DeSPAC transactions also hit an all?

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Cooley M&A

JANUARY 25, 2024

The higher interest rates escalated borrowing expenses, making mega-deals (deals valued at $5 billion or more) significantly more expensive, due to their heavy reliance on debt financing, and impacted valuation multiples with higher discount rates.

M&A 52

M&A Mergers and Acquisitions Investment Government 52